Advanced Filters
noise
Found 64,920 clinical trials
N Nadejda Lambert

Evaluating Primary Suicide Prevention in Adolescents With Risk Factors

Suicide is one of the main causes of death among teenagers. Because it is preventable, primary prevention of suicide has become a public health priority, with encouraging results in promoting suicide awareness and reducing suicidal thoughts among adolescents. However, the lack of studies conducted among vulnerable populations (i.e., marginalised, disengaged …

14 - 18 years of age All Phase N/A
Y Yekaterina Sherman, MD

Pleuroscopy First Versus Thoracentesis First in Patients with Suspected Malignant Pleural Effusions

This is a randomized control trial of patients with suspected malignant pleural effusions to compare whether patients who have a thoracentesis or pleuroscopy (pleural biopsy) obtain an adequate biopsy, achieve a diagnosis, and begin cancer-directed therapy faster.

18 years of age All Phase N/A

A Modular Phase 1/2 Study with CT7439 in Participants with Solid Malignancies

This modular, multi-part, multi-arm, Phase 1/2, FIH study allows the evaluation of the safety and tolerability of CT7439, dosed as a monotherapy and in combination with anticancer treatment in participants with solid malignancies.

18 years of age All Phase 1/2

Intracoronary rhTNK-tPA Versus Tirofiban in Patients With STEMI and High Thrombus Burden

The goal of this clinical trial is to compare the efficacy and safety of intracoronary rhTNK-tPA or Tirofiban in patients with ST-segment elevation myocardial infarction and high thrombus burden. The main questions it aims to answer are: Is the efficacy of intracoronary rhTNK-tPA non-inferior to intracoronary Tirofiban for the treatment …

18 - 75 years of age All Phase 4
A A B Srivastava, MD

Anxiety During Abstinence in AUD

The goal of this study is to better understand the underlying neurobiological basis of anxiety that emerges during abstinence in patients with alcohol use disorder (AUD). The main questions it aims to answer are: To characterize anxiety itself as well as anxiety related-neurobiological circuitry in early abstinence in AUD To …

21 - 39 years of age All Phase N/A
I Ikram Ali, Master

Effects of Intermittent Hypoxia in Upper and Lower Limb Functions in Persons With Incomplete Spinal Cord Injury

Spinal cord injury (SCI) is a devastating disability with physical, social and vocational consequences. Owing to its overwhelming complications, the cost of treatment and rehabilitation increases constantly. Persons with spinal cord injury are always dependent on their families in most of house hold, recreational and activities of daily life. Majority …

18 years of age All Phase N/A
C ChiouYi Ho

Perioperative Immunonutrition Under Enhanced Recovery After Surgery

The goal of this clinical trial is to compare the effect of perioperative immunonutrition supplement in gynecologic cancer patients. The main questions it aims to answer are: is there any difference in the nutritional outcomes and functional outcomes between intervention and conventional groups? is there any difference in the post-surgical …

18 - 80 years of age Female Phase N/A
F Francisco J Amaro-Gahete, MD, PhD

Virtual Reality Software for Patients With Stroke

The goal os this clinical trial is to develop and validate a gamified, fully immersive, and stroke-specific virtual reality software to improve physical disability and quality of life in patients with stroke. The main questions it aims to answer are: To assess the effects of a gamified, fully immersive and …

18 years of age All Phase N/A
K Kara Hoffman

A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC

The purpose of the study is to determine the activity and safety of ACR-368 (prexasertib) in combination with gemcitabine in participants with Head and Neck Squamous Cell Carcinoma (HNSCC). Participants will receive the study drugs ACR-368 and a low dose of gemcitabine once every 2 weeks in 4-week cycles and …

18 years of age All Phase 2
S Site Public Contact

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

This phase III trial compares the effect of adding cetuximab to pembrolizumab versus pembrolizumab alone in treating patients with head and neck squamous cell carcinoma (HNSCC) that has come back after a period of improvement (recurrent) and/or that has spread from where it first started (primary site) to other places …

18 years of age All Phase 3

Simplify language using AI